HomeEKTA-B • STO
add
Elekta AB (publ)
Previous close
kr 49.08
Day range
kr 48.60 - kr 49.26
Year range
kr 40.64 - kr 68.00
Market cap
17.94B SEK
Avg Volume
1.11M
P/E ratio
67.84
Dividend yield
4.93%
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jul 2025info | Y/Y change |
|---|---|---|
Revenue | 3.65B | -4.68% |
Operating expense | 1.14B | -5.85% |
Net income | 107.00M | 52.86% |
Net profit margin | 2.93 | 60.11% |
Earnings per share | 0.31 | -24.39% |
EBITDA | 347.00M | -10.80% |
Effective tax rate | 21.90% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jul 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.76B | 16.75% |
Total assets | 29.15B | -7.21% |
Total liabilities | 20.02B | -3.33% |
Total equity | 9.13B | — |
Shares outstanding | 382.08M | — |
Price to book | 2.06 | — |
Return on assets | 1.77% | — |
Return on capital | 3.09% | — |
Cash Flow
Net change in cash
| (SEK) | Jul 2025info | Y/Y change |
|---|---|---|
Net income | 107.00M | 52.86% |
Cash from operations | -86.00M | 82.56% |
Cash from investing | -274.00M | 33.01% |
Cash from financing | 126.00M | -75.00% |
Net change in cash | -195.00M | 53.01% |
Free cash flow | -397.12M | 53.31% |
About
Elekta is a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders. Elekta has a global presence in more than 120 countries, with over 40 offices around the world and about 4,700 employees. Wikipedia
Founded
1972
Website
Employees
4,485
